Although effective symptomatic treatments for Parkinson's disease (PD) have been available
for some time, efficient and well-controlled drug delivery to the brain has proven to be …

Current treatments for Parkinson's disease (PD) are aimed at addressing motor symptoms
but there is no therapy focused on modifying the course of the disease. Successful treatment …

Current therapies for Parkinson's disease are symptomatic and unable to regenerate the
brain tissue. In recent years, the therapeutic potential of a wide variety of neuroprotective …

Highlights•We describe the main clinical manifestations and pathogenesis of Parkinson's
disease.•We present a general overview of current treatments for Parkinson's disease.•We …

Abstract Parkinson's disease (PD), although being the second most prevalent
neurodegenerative disease (ND) encounters lack of definitive treatment and challenges in …

Nanoparticles might be produced and manipulated to present a large spectrum of
properties. The physicochemical features of the engineered nanomaterials confer to them …

Parkinson's disease (PD) affects around ten million people worldwide and is considered the
second most prevalent neurodegenerative disease after Alzheimer's disease. In addition …

Neurodegenerative disorders are consequences of the deterioration of cells and tissues with
a mature undesirable way of life. The degenerative disease like Parkinson's disease (PD) …

Parkinson's disease (PD) is becoming prevalent with the increasingly ageing global
population. PD is a multi-factorial disease for which there is currently no cure but only …

Background: Although a variety of therapeutic approaches are available for the treatment of
Parkinson's disease, challenges limit effective therapy. Among these challenges are delivery …